血液透析患者的多药性和肉症:SARC-HD研究的结果
Marvery P Duarte1, Nicolle P Marinheiro2, Odimar Q Junior2
1Faculty of Health Sciences, University of Brasilia, Brasília, Brazil.
Aging clinical and experimental research
|June 18, 2025
概括
多药性,即使用多种药物,与血液透析患者的肌肉强度低下有关. 过多药性 (≥10种药物) 与肌肉强度降低有显著的关联,但与萨尔科佩尼亚本身无关.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 老年病的医生 老年病的医生
- 临床药理学 临床药理学
背景情况:
- 多药在接受血液透析的患者中很常见.
- 标志着肌肉损失的萨尔科佩尼亚在这个人群中是一个重大问题.
- 在血液透析患者中,多药和肉症之间的关系需要进一步调查.
研究的目的:
- 调查在血液透析患者中多药和肉病之间的关联.
- 为了确定处方药的数量是否与肉类的患病率或严重程度相关.
主要方法:
- 来自SARC-HD研究的数据的横截面分析.
- 患者分为没有多药 (0-4),多药 (5-9) 和超多药 (≥10种药物) 的患者.
- 使用适应的EWGSOP2共识标准诊断和分阶段的肉类瘤.
主要成果:
- 超多药性与较差的身体功能有关.
- 45%的患者患有低肌肉强度;21%的患者患有肉症.
- 超多药性独立与肌肉强度低相关 (64%更高的几率);与肉症没有显著的关联. 额外的两种药物每次增加10%的低肌肉强度概率.
结论:
- 药物的数量,特别是多重药物,独立地与血液透析患者的肌肉强度低有关.
- 在这个队列中,多药性与萨尔科佩尼亚本身没有显著的关联.
- 在血液透析患者的肌肉健康方面,需要对药物负担给予临床关注.
相关概念视频
Heart Failure VI: Adjunct Therapies
39
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
39
Chronic Kidney Disease III: Interprofessional Care
84
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
84
Peritoneal Dialysis III: Nursing Management
159
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
159
Hemodialysis II: Procedure and Complications
146
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
146
Chronic Kidney Disease II: Clinical Manifestations
107
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
107
Renal Failure: Dose Adjustments
167
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
167


